Ophthalmologic Drug Guide: Edition 2
2010年11月 · Springer Science & Business Media
5.0star
1 則評論report
電子書
138
頁數
report評分和評論未經驗證 瞭解詳情
關於這本電子書
Drug therapy as an alternative to surgical intervention is becoming increasingly common. In the past five years, new anti-glaucoma agents have becoming increasingly effective. This edition will include new information on off-label prescribing and cap colors where they are mandated by the FDA (pink/white for steroid drops, grey for topical NSAIDS, etc.);There are now several new pharmaceutical agents being used to treat retinal diseases such as age-related macular degeneration (Macugen, Lucentis, Visudyne), while other drugs formerly prescribed have now been shown to be less effective. Intraocular infections are primarily treated with intravitreal medications. Additionally, the anti-allergy and dry eye markets continue to grow, with a new formulation of Allergan's Acular 0.5% (ketorolac tromethamine) and Elestat ophthalmic solution, its new antihistamine-mast cell stabilizer.
評分和評論
5.0
1 則評論
關於作者
Douglas J. Rhee, MD Assistant Professor Harvard Medical School Associate Chief, Practice Development Massachusetts Eye & Ear Infirmary Boston, Massachusetts USA Katheryn A. Colby, MD, PhD Assistant Professor Harvard Medical School Cornea Service Massachusetts Eye & Ear Infirmary Boston, Massachusetts USA Christopher J. Rapuano, MD Professor Jefferson Medical College Director, Cornea Service Wills Eye Hospital Philadelphia, Pennsylvania USA Lucia Sobrin, MD, MPH Assistant Professor Harvard Medical School Massachusetts Eye & Ear Infirmary Boston, Massachusetts USA
為這本電子書評分
請分享你的寶貴意見。
閱讀資訊
智能手機和平板電腦
手提電腦和電腦
你可以使用電腦的網絡瀏覽器聆聽在 Google Play 上購買的有聲書。
電子書閱讀器及其他裝置
如要在 Kobo 等電子墨水裝置上閱覽書籍，你需要下載檔案並傳輸到你的裝置。請按照說明中心的詳細指示，將檔案傳輸到支援的電子書閱讀器。
